Revolutionizing Cancer Diagnosis: The Rise of Frozen Biopsy and Its Impact on Patient Outcomes

The use of frozen biopsy, also known as direct biopsy or rapid histopathological testing, is crucial in determining the nature of tumor tissue and whether it is benign or malignant. This procedure can provide accurate results within 15-30 minutes, making it an essential tool in surgical decision-making and increasing the success rate of operations and follow-up treatments. Dr. Nguyen Van Thay, deputy pathologist at Tam An General Hospital in Ho Chi Minh City, emphasized the importance of this technique in guiding surgeons in their course of action and improving patient outcomes.

For patients with early-stage breast cancer, a frozen sentinel lymph node biopsy can be particularly beneficial in determining the spread of malignant cells. By examining the first lymph node along the lymphatic drainage pathway, doctors can assess the risk of cancer spreading to other nodes in the armpit. This information helps inform whether axillary lymph nodes need to be removed to prevent complications such as arm lymphedema, decreased sensation, and limited mobility.

The Pathology Unit at Tam An General Hospital routinely receives frozen biopsy specimens for evaluation by an experienced team of pathologists who perform rapid analyses to provide accurate results that guide surgeons in making informed decisions. With the use of these techniques, patients like Ms. Hong underwent precise surgical procedures that minimized complications and improved treatment outcomes.

In conclusion, frozen biopsy plays a critical role in determining tumor tissue nature, assessing resection margins, identifying metastatic cells in lymph nodes and providing rapid decision-making capabilities that ultimately benefit patients by reducing repeat procedures and ensuring successful treatment outcomes.